POMPANO BEACH, Fla., Oct. 12, 2017 /PRNewswire/ -- Prescriber's Choice Inc. and Sincerus Florida LLC -- two companies thatare revolutionizing the way that pharmaceutical drugs are dispensed -- announced that they have filed counterclaims in their lawsuit against the Bio-pharma giant Allergan plc. The counterclaim alleges that Allergan representatives use false and misleading
Commenting on the lawsuit, the companies issued the following statement:
"Prescriber's Choice and Sincerus Florida are saddened that a Biopharmaceutical company as large as Allergan must resort to using unscrupulous tactics to mislead prescribers. Rather than relying on the strength of their branded products, they have resorted to telling lies and using bully tactics to instill uncertainty and fear. Today, in true David vs Goliath fashion, we have fired back at the giant by bringing suit against them. Prescriber's Choice and Sincerus Florida have an altruistic vision to provide access to customized affordable medications. This suit is another step in the fight to bring safe innovation to doctors, patients, and the healthcare system."
About Prescriber's Choice Inc and Sincerus Florida, LLC
Prescriber's Choice Inc. and Sincerus Florida LLC are two companies working together to change the paradigm of drug dispensing. Prescriber's Choice which serves as a marketing and consulting arm for Sincerus Florida, a FDA Registered 503B Outsourcing Facility, both work with prescribers to create their own customized formulary, dispense the personalized medications at the time of the patient visit, and allow patients affordable access to drugs. Most of the time, the customized drugs that are dispensed are less than the patients' copayment at the pharmacy on a commercially available drug.
Prescriber's Choice and Sincerus Florida are paving the way for a more streamlined access to medications. Thousands of prescribers around the nation have implemented this streamlined approach. The goals of Prescriber's Choice and Sincerus Florida are to help prescribers so that they can enhance their patients' understanding, increase their patients' compliance, and improve their patients' outcomes.
View original content:http://www.prnewswire.com/news-releases/more-bad-news-for-allergan-plc--prescribers-choice-inc-and-sincerus-florida-llc-file-suit-against-allergan-for-unfair-trade-practices-300536205.html
SOURCE Prescriber's Choice
Subscribe to our Free Newsletters!
Alström syndrome, a rare genetic disorder due to ALMS1 mutations, occurs in the first year of ...
Sodium zirconium cyclosilicate was approved by FDA recently to use as an oral suspension for ...
Encephalocele is a birth defect where a sac like protrusion of brain and covering membranes occurs ...View All